Despite assertions that it exerts a tumor-suppressive role in PCa, NKX3.1 has become an excellent and widely used IHC biomarker for metastasis of prostatic origin; it is even more reliable than traditional AR or prostate-specific antigen (PSA) staining [23]. The gene discussed is AR; the disease is posterior cortical atrophy.